// App-Quantinova.ai

1200 : Anti-Cyclic Citrullinated Peptide Antibodies in Idiopathic Pulmonary Fibrosis Are Not Citrulline-Specific: Implications for the Pathogenesis of Rheumatoid Arthritis

Researchers

Presenter

  • Elena B. Lugli

Principal Investigators

  • Muslima Chowdhury

  • Peter J. Charles

  • Michael G. Crooks

  • Simon P. Hart

  • Patrick Venables

  • Benjamin A. Fisher

Medical Centers

  • Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom

  • Castle Hill Hospital, Hull York Medical School, Cottingham, United Kingdom

  • Oxford University, Kennedy Institute of Rheumatology, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Idiopathic pulmonary fibrosis

  • Rheumatoid arthritis

  • Pulmonary fibrosis

  • Inflammatory Arthritis

Biomarkers

  • ATP/GTP Binding Protein 1

Drug/Treatment

  • citrulline

  • Fibrinogen (IV)

  • Arginine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved